All posts by: Michael Zand

About Michael Zand

The Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor Day – GlobeNewswire (press release)

Continue reading

2018-03-28 NEWS

The Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor Day
GlobeNewswire (press release)
This year’s Cell & Gene Therapy Investor Day is expected to attract more than 350 attendees, including nearly 200 active investors and analysts. With presentations from more than 35 of the sector’s most promising companies, along with panels and

and more »

Continue reading

2018-03-28 NEWS

Phys.Org

Novel synthetic biology technique could lead to breakthroughs in disease treatment
Phys.Org
This work represents a significant development in synthetic biology, according to Wilson Wong, a biomedical engineering researcher at Boston University who was not involved in this research. Wong focuses on cellular immunotherapy—the use of the body’s

and more »

Continue reading

2018-03-28 NEWS

Speak Up About Immunotherapy’s Side Effects
Curetoday.com
Sometimes patients may not report side effects to their health care team, in fear of their oncologist taking them off a drug that could prolong their survival. BY Brielle Urciuoli. PUBLISHED March 28, 2018. Sometimes patients may not report side